Salicylic acid

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the relief of acne. It provides a comprehensive four-in-one skin care solution, which includes gentle cleansing, hydration, balancing, and nourishment of the skin.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to instruct patients to use the cleansing cloths daily prior to the application of any skin treatment, mask, or moisturizer.

To utilize the cleansing cloths, the patient should first lift the seal and remove one cloth from the package. The cloth should be gently used to wipe the face, effectively removing dirt, sweat, oil, and makeup. It is important to note that rinsing is not required after use.

Care should be taken to avoid direct contact with the eyes and mouth during the cleansing process. After use, the package should be resealed tightly to maintain the moisture of the remaining cloths.

Patients should be informed to dispose of the used cleansing cloth in the trash and not to flush it down the toilet.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with a known allergy to salicylic acid or any other ingredient in this formulation.

• Children under 12 years of age, unless specifically directed by a healthcare professional.

• Application on inflamed or weeping skin, as well as on open wounds, due to the potential for exacerbation of the condition.

In the event of irritation or rash that persists, discontinue use and consult a physician. Additionally, avoid contact with the eyes, lips, and mouth; if contact occurs, rinse thoroughly with water.

Warnings and Precautions

For external use only. The product is intended solely for topical application and should not be ingested or applied to mucous membranes.

The disposable wipes are designed for one-time use only. Reusing these wipes may compromise their effectiveness and increase the risk of contamination.

Healthcare professionals should advise patients to discontinue use and consult a physician if any irritation or rash develops and persists. Monitoring for such adverse reactions is essential to ensure patient safety and appropriate management.

Side Effects

Patients should be aware that the product is intended for external use only and is designed for one-time use as disposable wipes.

In clinical practice, it is advised that patients discontinue use and consult a healthcare professional if any irritation or rash develops and persists. This precaution is essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Facial Cleansing Wipes. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication unless specifically directed by a healthcare professional. Caution is advised when considering treatment options for this age group, and healthcare providers should evaluate the risks and benefits before prescribing.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, there are no established safety concerns, dosage modifications, or special precautions outlined for pregnant patients. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and weigh the potential risks and benefits. It is advisable to monitor any emerging data related to fetal outcomes as it becomes available.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and intervention strategies.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No relevant information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no pertinent data concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep wipes and plastic bags out of reach of babies, children, and pets to prevent the risk of choking and suffocation. Patients should be informed that if they have a known allergy to salicylic acid or any other ingredient in the product, they should refrain from using it.

It is important to communicate that this product should not be used on children under 12 years of age unless specifically directed by a doctor. Additionally, patients should be cautioned against using the product on inflamed or weeping skin, as well as on open wounds.

Patients should be instructed to stop using the product and consult a doctor if they experience any irritation or rash that persists. They should also be made aware to avoid contact with the eyes, lips, and mouth; in the event of contact, they should rinse the area thoroughly with water.

Finally, patients should be informed that the product is intended for use 1-2 times daily or as directed by a healthcare professional.

Storage and Handling

The product is supplied with a validity period of 2 years. It should be stored in a cool, dry, and airy place, ensuring that the temperature does not exceed 106°F (41°C). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered topically, with a recommended usage of 1-2 times daily or as directed by a healthcare professional. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Facial Cleansing Wipes, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)